About Scipio bioscience

SCIPIO BIOSCIENCE – “single-cell profiling for every benchtop”
Scipio Bioscience develops an innovative, user-friendly, and inexpensive kit enabling life scientists to prepare their own samples for single-cell sequencing.
Scipio Bioscience aims at democratizing single-cell analysis by providing the reference sample preparation tool for every academic and clinical research laboratory.

Press releases

25. February 2020

Scipio bioscience raises €6.0 M Series A financing to develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing

Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. The initial shareholders Seventure Partners’ Quadrivum I (Paris, France) and High-Tech Gründerfonds (Bonn, Germany) participated in the capital increase, alongside additional investo


Institut du Cerveau et de la Moelle épinière
47 boulevard de l'hôpital
75013 Paris

In portfolio

15. Nov 2017



Dr. Frank Hensel

Principal / Authorized signatory